← Home
🚀 Sign up Free for Company Insights & Valuation!
Sign up for free to get access to the best public company valuation and insights. Get started today and unlock the potential of your investments!
Sign up free
Ipsen
-4.64%
Pharma / Pharmaceuticals, Biotechnology
At a Glance | Core Facts | Company Due Diligence | Industry Due Diligence | Competitors | Stock Swings | News | Income | Balance | Cash Flow | Growth | Enterprise | Ratios | Metrics | Dividends | Risks | SWOT | Porter's Five Forces | PEST | Score Positive | Clusters | Reports | WebBalance Sheet
Pay attention and research significant changes from year to year values. [ ! ]
| Fixed Column | Cash And Cash Equivalents | Short Term Investments | Cash And Short Term Investments | Net Receivables | Inventory | Other Current Assets | Total Current Assets | Property Plant Equipment Net | Goodwill | Intangible Assets | Goodwill And Intangible Assets | Long Term Investments | Tax Assets | Other Non Current Assets | Total Non Current Assets | Other Assets | Total Assets | Account Payables | Short Term Debt | Tax Payables | Deferred Revenue | Other Current Liabilities | Total Current Liabilities | Long Term Debt | Deferred Revenue Non Current | Deferred Tax Liabilities Non Current | Other Non Current Liabilities | Total Non Current Liabilities | Other Liabilities | Capital Lease Obligations | Total Liabilities | Preferred Stock | Common Stock | Retained Earnings | Accumulated Other Comprehensive Income Loss | Other Total Stockholders Equity | Total Stockholders Equity | Total Equity | Total Liabilities And Stockholders Equity | Minority Interest | Total Liabilities And Total Equity | Total Investments | Total Debt | Net Debt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-12 | 678.1 | 1.1 | 679.2 | 0.0 | 285.5 | 1056.5 | 2021.2 | 664.2 | 699.5 | 2518.4 | 3217.9 | 174.2 | 284.7 | 76.8 | 4417.8 | 0.0 | 6439.0 | 854.8 | 37.2 | 79.3 | 0.0 | 534.1 | 1505.4 | 389.6 | 36.79 | 55.2 | 270.2 | 751.8 | 0.0 | 138.69 | 2257.19 | 0.0 | 83.8 | 345.9 | 0.0 | 3751.9 | 4181.6 | 4181.8 | 6439.0 | 0.2 | 6439.0 | 175.3 | 426.8 | -251.3 |
| 2023-12 | 528.4 | 0.0 | 528.4 | 631.29 | 289.5 | 449.2 | 1898.4 | 574.6 | 663.9 | 2678.8 | 3342.7 | 131.69 | 0.0 | 375.5 | 4424.5 | 0.0 | 6322.9 | 771.4 | 36.4 | 41.4 | 0.0 | 777.6 | 1626.8 | 269.7 | 0.0 | 0.0 | 602.6 | 872.3 | 0.0 | 27.4 | 2499.1 | 3.9 | 83.8 | 644.4 | 3082.09 | 14.8 | 3825.1 | 3823.8 | 6322.9 | -1.3 | 6322.9 | 131.69 | 306.1 | -222.3 |
| 2022-12 | 1169.3 | 31.0 | 1200.3 | 632.5 | 284.1 | 311.7 | 2397.6 | 581.4 | 579.9 | 1585.4 | 2165.3 | 105.3 | 321.1 | 37.2 | 3210.3 | 0.0 | 5607.9 | 647.1 | 31.5 | 11.8 | 5.2 | 645.0 | 1335.4 | 663.8 | 103.7 | 77.9 | 272.0 | 935.8 | 0.0 | 109.7 | 2271.19 | 0.0 | 83.8 | 648.6 | 3238.4 | 8.4 | 3337.3 | 3336.7 | 5607.9 | -0.6 | 5607.9 | 136.3 | 667.6 | -501.7 |
| 2021-12 | 814.7 | 42.4 | 857.1 | 564.29 | 219.4 | 355.4 | 1953.8 | 647.5 | 623.1 | 1391.9 | 2015.0 | 90.7 | 253.1 | 46.7 | 3053.0 | 0.0 | 5006.8 | 594.7 | 35.29 | 66.0 | 258.6 | 273.8 | 1228.4 | 657.8 | 45.8 | 101.8 | 366.6 | 1024.4 | 0.0 | 124.8 | 2252.8 | 0.0 | 83.8 | 646.6 | 2652.2 | 15.5 | 2751.5 | 2754.0 | 5006.8 | 2.5 | 5006.8 | 133.1 | 693.1 | -121.6 |
Wait! There's more — sign up for free or log in